Internet-Based Management for Depressive Disorder

  • Zuowei WangEmail author
  • Zhiang Niu
  • Lu Yang
  • Lvchun Cui
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 1180)


The advances in the Internet and related technologies may lead to changes in professional roles of psychiatrists and psychotherapists. The application of artificial intelligence (AI) and electronic measurement-based care (eMBC) in the treatment of depressive disorder has addressed more interest. AI could play a role in population health management and patient administration as well as assist physicians to make a decision in the real-world clinical practice. The eMBC strengthens MBC through web/mobile devices and telephone consulting services, to monitor disease progression, and customizes the MBC interface in electronic medical record systems (EMRs).


Depressive disorder Therapy Artificial intelligence (AI) Measurement-Based Care (MBC) 


  1. Abbasi J (2017) 23andMe, big data, and the genetics of depression. JAMA 317(1):14–16CrossRefGoogle Scholar
  2. Abbott CC, Loo D, Sui J (2016) Determining electroconvulsive therapy response with machine learning. JAMA Psychiatry 73(6):545–546CrossRefGoogle Scholar
  3. Aziz HA (2016) Handling big data in modern healthcare. Lab Med 47(4):e38–e41CrossRefGoogle Scholar
  4. Bauer AM, Baldwin SA, Anguera JA et al (2018) Comparing approaches to mobile depression assessment for measurement-based care: prospective study. J Med Internet Res 20(6):e10001CrossRefGoogle Scholar
  5. Bremer V, Becker D, Kolovos S et al (2018) Predicting therapy success and costs for personalized treatment recommendations using baseline characteristics: data-driven analysis. J Med Internet Res 20(8):e10275CrossRefGoogle Scholar
  6. Chekroud AM, Zotti RJ, Shehzad Z et al (2016) Cross-trial prediction of treatment outcome in depression: a machine learning approach. Lancet Psychiatry 3(3):243–250CrossRefGoogle Scholar
  7. Cho CH, Lee T, Kim MG et al (2019) Mood prediction of patients with mood disorders by machine learning using passive digital phenotypes based on the circadian rhythm: prospective observational cohort study. J Med Internet Res 21(4):e11029CrossRefGoogle Scholar
  8. CMHA-BC (2016) Bounce back: reclaim your health. Annual Report, 2015–2016. Canadian Mental Health Association, Vancouver, BCGoogle Scholar
  9. Cohen ZD, Derubeis RJ (2018) Treatment selection in depression. Annu Rev Clin Psychol 14:209–236CrossRefGoogle Scholar
  10. Diniz BS, Lin CW, Sibille E et al (2016) Circulating biosignatures of late-life depression (LLD): towards a comprehensive, data-driven approach to understanding LLD pathophysiology. J Psychiatr Res 82:1–7CrossRefGoogle Scholar
  11. Dipnall JF, Pasco JA, Berk M et al (2017) Why so GLUMM? Detecting depression clusters through graphing lifestyle-environs using machine-learning methods (GLUMM). Eur Psychiatry 39:40–50CrossRefGoogle Scholar
  12. Ferrari P, Parisi MM, Colombo R et al (2018) Depression and mania induce pro-inflammatory activation of macrophages following application of serum from individuals with bipolar disorder. Clin Psychopharmacol Neurosci 16(1):103–108CrossRefGoogle Scholar
  13. Goldberg SB, Buck B, Raphaely S et al (2018) Measuring psychiatric symptoms remotely: a systematic review of remote measurement-based care. Curr Psychiatry Rep 20(10):81CrossRefGoogle Scholar
  14. Goldstein LA, Connolly Gibbons MB, Thompson SM et al (2011) Outcome assessment via handheld computer in community mental health: consumer satisfaction and reliability. J Behav Health Serv Res 38(3):414–423CrossRefGoogle Scholar
  15. Horvitz E, Mulligan D (2015) Policy forum. Data, privacy, and the greater good. Science 349(6245):253–255CrossRefGoogle Scholar
  16. Khodayarirostamabad A, Reilly JP, Hasey GM et al (2013) A machine learning approach using EEG data to predict response to SSRI treatment for major depressive disorder. Clin Neurophysiol 124(10):1975–1985CrossRefGoogle Scholar
  17. Koutsouleris N, Kambeitz-Ilankovic L, Ruhrmann S et al (2018) Prediction models of functional outcomes for individuals in the clinical high-risk state for psychosis or with recent-onset depression: a multimodal, multisite machine learning analysis. JAMA Psychiatry 75(11):1156–1172CrossRefGoogle Scholar
  18. Lam RW, Milev R, Rotzinger S et al (2016) Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort. BMC Psychiatry 16:105CrossRefGoogle Scholar
  19. Lewis CC, Scott K, Marti CN et al (2015) Implementing measurement-based care (iMBC) for depression in community mental health: a dynamic cluster randomized trial study protocol. Implement Sci 10:127CrossRefGoogle Scholar
  20. Maciukiewicz M, Marshe VS, Hauschild AC et al (2018) GWAS-based machine learning approach to predict duloxetine response in major depressive disorder. J Psychiatr Res 99:62–68CrossRefGoogle Scholar
  21. Mourao-Miranda J, Almeida JR, Hassel S et al (2012) Pattern recognition analyses of brain activation elicited by happy and neutral faces in unipolar and bipolar depression. Bipolar Disord 14(4):451–460CrossRefGoogle Scholar
  22. Mwangi B, Ebmeier KP, Matthews K et al (2012) Multi-centre diagnostic classification of individual structural neuroimaging scans from patients with major depressive disorder. Brain 135(Pt 5):1508–1521CrossRefGoogle Scholar
  23. Oslin DW, Hoff R, Mignogna J et al (2019) Provider attitudes and experience with measurement-based mental health care in the VA implementation project. Psychiatr Serv 70(2):135–138CrossRefGoogle Scholar
  24. Perlis RH (2013) A clinical risk stratification tool for predicting treatment resistance in major depressive disorder. Biol Psychiatry 74(1):7–14CrossRefGoogle Scholar
  25. Redlich R, Opel N, Grotegerd D et al (2016) Prediction of individual response to electroconvulsive therapy via machine learning on structural magnetic resonance imaging data. JAMA Psychiatry 73(6):557–564CrossRefGoogle Scholar
  26. Topolovec-Vranic J, Cullen N, Michalak A et al (2010) Evaluation of an online cognitive behavioural therapy program by patients with traumatic brain injury and depression. Brain Inj 24(5):762–772CrossRefGoogle Scholar
  27. Trivedi MH, Rush AJ, Wisniewski SR et al (2006) Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 163(1):28–40CrossRefGoogle Scholar
  28. Trivedi MH, Rush AJ, Gaynes BN et al (2007) Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR*D measurement-based care. Neuropsychopharmacology 32(12):2479–2489CrossRefGoogle Scholar
  29. Victor E, Aghajan ZM, Sewart AR et al (2019) Detecting depression using a framework combining deep multimodal neural networks with a purpose-built automated evaluation. Psychol AssessGoogle Scholar
  30. Waldrop J, Mcguinness TM (2017) Measurement-based care in psychiatry. J Psychosoc Nurs Ment Health Serv 55(11):30–35CrossRefGoogle Scholar
  31. Watson DS, Krutzinna J, Bruce IN et al (2019) Clinical applications of machine learning algorithms: beyond the black box. BMJ 364:l886CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  1. 1.Hongkou District Mental Health CenterShanghaiChina
  2. 2.Division of Mood Disorders, Shanghai Mental Health CenterShanghai Jiao Tong University School of MedicineShanghaiChina

Personalised recommendations